Biosign Technologies Inc. announced that the demand loans payable to Quindell Solutions Inc. totaling $6.8 million plus all accrued interest of circa $180,000 have been converted to a loan repayable over a period of 5 years. The Term Loan accrues interest at the rate of 2% per annum above prime rate. The first payment of $1,360,000 together with interest is due in December 2015 and subsequent payments of $680,000 together with interest are due every six months thereafter.

The final payment in December 2019 will also include the Accrued Interest.